electroCore, Inc.

medical devices

About

electroCore, Inc. is a bioelectronic medicine and medical technology company based in Basking Ridge, New Jersey. Founded in 2005, it focuses on developing non-invasive vagus nerve stimulation (nVNS) therapies for neurological and pain-related conditions. The company went public in 2018 and is led by CEO Daniel S. Goldberger. The flagship product, gammaCore, is a handheld device that delivers nVNS and is FDA-cleared for treating pain associated with episodic cluster headaches and migraines. It also received emergency FDA authorization for use in COVID-19 patients experiencing respiratory distress. Additionally, electroCore offers Truvaga, a consumer wellness product line, and TAC-STIM, a bioelectronic therapy aimed at enhancing human performance. The company is committed to clinical research and development, focusing on expanding its technology's applications to various neurological disorders.

Technologies

Amazon SES Gmail Outlook Google Apps Drupal The Trade Desk Remote

Keywords

neuromodulation neuroscience bioelectronic medicine healthcare biotechnology: electromedical & electrotherapeutic apparatus health care medical equipment manufacturing neuromodulation device digital health solutions pain management technology bioelectronic treatment bioelectronic medicine for pain medical device r&d patent portfolio environmentally sustainable medical devices healthcare technology medical device telemedicine patient treatment virtual patient care covid-19 operational enhancements clinical research sustainable medical devices gammacore digital health vagus nerve stimulation safety and compliance patents chronic condition therapy environmentally friendly medical device

Location

200 Forge Way, Rockaway, New Jersey, United States, 07866-2055

Related Companies

Companies in the same industry